APA (7th ed.) Citation

Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., . . . Zannad, F. (2020). Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. The New England journal of medicine, 383(15), 1413-1424. https://doi.org/10.1056/NEJMoa2022190

Chicago Style (17th ed.) Citation

Packer, Milton, et al. "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure." The New England Journal of Medicine 383, no. 15 (2020): 1413-1424. https://doi.org/10.1056/NEJMoa2022190.

MLA (9th ed.) Citation

Packer, Milton, et al. "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure." The New England Journal of Medicine, vol. 383, no. 15, 2020, pp. 1413-1424, https://doi.org/10.1056/NEJMoa2022190.